✦ LIBER ✦

P213. Persistent pain as a prognostic factor of residual/recurrent tumor in head and neck cancer

✍ Scribed by P. Karnam; A. Suresh; N. Trivedi; V. Kekatpure; M.A. Kuriakose

Book ID: 113833998
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 35 KB
Volume: 47
Category: Article
ISSN: 1368-8375
DOI: 10.1016/j.oraloncology.2011.06.456

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor volume as prognostic factor in che

Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer

✍ Joost L. Knegjens; Michael Hauptmann; Frank A. Pameijer; Alfons J. Balm; Frank J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views

## Abstract ## Background Tumor volume is an important predictor of outcome in radiotherapy alone. Its significance in concomitant chemoradiation (CCRT) is much less clear. We analyzed the prognostic value of primary tumor volume for advanced head and neck squamous cell carcinoma (HNSCC) treated w

Usefulness of Tumor Volumetry as a Progn

Usefulness of Tumor Volumetry as a Prognostic Factor of Survival in Head and Neck Cancer

✍ Ralf Kurek; Anna Kalogera-Fountzila; Klaus Muskalla; Urania Dafni; Thomas Schnab 📂 Article 📅 2003 🏛 Springer 🌐 German ⚖ 105 KB

Recurrence at the primary site in head a

Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor

✍ Charles R. Leemans; Rammohan Tiwari; Jos J. P. Nauta; Isaac Van Der Waal; Gordon 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

Background. Biologic aggressiveness of head and neck carcinoma is reflected in its capability to metastasize to regional lymph nodes and its propensity to recur after treatment. Methods. The authors report on 244 patients treated at the Department of Otolaryngology-Head and Neck Surgery of the Free

Recurrence at the primary site in head a

Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor

✍ Tideman, H. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 110 KB

hsa-miR-210 is a marker of tumor hypoxia

hsa-miR-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer

✍ Harriet E. Gee; Carme Camps; Francesca M. Buffa; Shalini Patiar; Stuart C. Winte 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

## Abstract ## BACKGROUND: Hypoxia is an important mechanism of treatment resistance in head and neck squamous cell carcinoma (HNSCC). MicroRNAs are short noncoding RNAs that regulate multiple mRNAs and are frequently dysregulated in cancer. The authors have investigated the role of 3 microRNAs, i

Role of EGFR as a prognostic factor for

Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis

✍ Keren, Shen; Shoude, Zhang; Lu, Zhao; Beibei, Yang 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 797 KB